Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 December 2003

Anticardiolipin antibody of adolescents and age of myocardial infarction in parents

Roya Kelishadi, Babak Sabet, Alireza Khosravi

Med Sci Monit 2003; 9(12): CR515-518 :: ID: 13424

Abstract

Background:The objective of our research was to study anticardiolipin antibody (ACLA) in the offspring of families at high risk for premature coronary heart disease (CHD) in comparison to controls, and the degree of agreement between ACLA levels in parents and children.Material/Methods:In an analytical case-control study, three paired parent-child groups of 50 each were selected by simple random sampling, and their IgG ACLA levels measured by ELISA method. A comparison was made between parents who had premature myocardial infarction (MI55 years and one child, and parents with no history of heart attacks and one child as the first and second control groups, respectively.Results:The prevalence of positive ACLA in adolescents in the case group was significantly higher than the second control group (P=0.03), but this difference was not significant against the first control group (p>0.05). Regarding parents, there were significant differences between the case group and both control groups (P=0.04 and P=0.009, respectively). A substantial degree of correlation was found between positive ACLA in patients with premature MI and their children (kappa correlation coefficient =0.63, 95% CI, 0.47–0.79).Conclusions:The findings of this study point to the probable presence of a familial immunological background in the onset of premature atherosclerosis with regard to ACLA, which can be measured as a risk factor in predicting premature CHD.

Keywords: Adolescent, Antibodies, Anticardiolipin - blood, Case-Control Studies, Child, Myocardial Infarction - genetics, Myocardial Infarction - immunology, Parents, Risk Factors

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750